Humoral and cellular immune response to second and third severe acute respiratory syndrome coronavirus 2 mRNA vaccine in patients with plasma cell dyscrasia.

Tomotaka Suzuki Shigeru KusumotoYoshiko KamezakiMasahide OkiNozomi NishitarumizuYoko NakanishiYukiyasu KatoAkimi KawaiNaohiro MatsunagaToru EbinaTomoyuki NakamuraYoshiaki MarumoKana OiwaShiori KinoshitaTomoko NaritaAsahi ItoAtsushi InagakiMasaki RiHirokazu KomatsuTakashi AritsuShinsuke Iida

Published in: Cancer medicine (2023)

This study highlighted the significance of booster SARS-CoV-2 mRNA vaccination in patients with PCD with respect to humoral and cellular immunity. Moreover, this study highlighted the potential impact of certain drug subclasses on vaccine-induced humoral immune response.

Keyphrases

immune response
sars cov
respiratory syndrome coronavirus
dendritic cells
toll like receptor
risk assessment
emergency department
cell therapy
inflammatory response
high glucose
bone marrow
drug induced